NR1H3, nuclear receptor subfamily 1 group H member 3, 10062
N. diseases: 102; N. variants: 10
Source: ALL
Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
0.716 | 0.360 | 11 | 47264739 | intron variant | T/C | snv | 0.38 |
|
0.800 | 1.000 | 2 | 2009 | 2012 | ||||||||
|
1.000 | 0.040 | 11 | 47253513 | intron variant | G/A | snv | 0.34 |
|
Nutritional and Metabolic Diseases | 0.800 | 1.000 | 1 | 2012 | 2012 | |||||||
|
0.925 | 0.080 | 11 | 47268596 | missense variant | G/A | snv | 2.2E-04 | 2.6E-04 |
|
Immune System Diseases; Nervous System Diseases | 0.740 | 1.000 | 4 | 2016 | 2016 | ||||||
|
0.716 | 0.360 | 11 | 47264739 | intron variant | T/C | snv | 0.38 |
|
Cardiovascular Diseases | 0.710 | 1.000 | 2 | 2011 | 2016 | |||||||
|
0.716 | 0.360 | 11 | 47264739 | intron variant | T/C | snv | 0.38 |
|
0.700 | 1.000 | 2 | 2009 | 2012 | ||||||||
|
1.000 | 0.040 | 11 | 47253513 | intron variant | G/A | snv | 0.34 |
|
0.700 | 1.000 | 1 | 2018 | 2018 | ||||||||
|
1.000 | 0.040 | 11 | 47253513 | intron variant | G/A | snv | 0.34 |
|
0.700 | 1.000 | 1 | 2018 | 2018 | ||||||||
|
0.827 | 0.280 | 11 | 47255124 | intron variant | A/G | snv | 0.19 |
|
Mental Disorders | 0.700 | 1.000 | 1 | 2018 | 2018 | |||||||
|
0.827 | 0.280 | 11 | 47255124 | intron variant | A/G | snv | 0.19 |
|
Mental Disorders | 0.700 | 1.000 | 1 | 2018 | 2018 | |||||||
|
0.790 | 0.320 | 11 | 47260473 | missense variant | C/T | snv | 0.26 | 0.26 |
|
0.700 | 1.000 | 1 | 2012 | 2012 | |||||||
|
0.790 | 0.320 | 11 | 47260473 | missense variant | C/T | snv | 0.26 | 0.26 |
|
0.700 | 1.000 | 1 | 2012 | 2012 | |||||||
|
0.790 | 0.320 | 11 | 47260473 | missense variant | C/T | snv | 0.26 | 0.26 |
|
0.700 | 1.000 | 1 | 2018 | 2018 | |||||||
|
0.716 | 0.360 | 11 | 47264739 | intron variant | T/C | snv | 0.38 |
|
0.700 | 1.000 | 1 | 2018 | 2018 | ||||||||
|
0.827 | 0.400 | 11 | 47259211 | 5 prime UTR variant | G/A | snv | 0.14 | 0.12 |
|
Nutritional and Metabolic Diseases | 0.020 | 1.000 | 2 | 2008 | 2013 | ||||||
|
0.827 | 0.400 | 11 | 47259211 | 5 prime UTR variant | G/A | snv | 0.14 | 0.12 |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Endocrine System Diseases | 0.020 | 0.500 | 2 | 2012 | 2014 | ||||||
|
0.882 | 0.160 | 11 | 47259102 | splice region variant | G/A | snv | 0.11 |
|
Nutritional and Metabolic Diseases | 0.020 | 1.000 | 2 | 2008 | 2019 | |||||||
|
0.790 | 0.320 | 11 | 47260473 | missense variant | C/T | snv | 0.26 | 0.26 |
|
Pathological Conditions, Signs and Symptoms; Nutritional and Metabolic Diseases | 0.020 | 1.000 | 2 | 2006 | 2015 | ||||||
|
0.790 | 0.320 | 11 | 47260473 | missense variant | C/T | snv | 0.26 | 0.26 |
|
Immune System Diseases; Nervous System Diseases | 0.020 | 1.000 | 2 | 2016 | 2018 | ||||||
|
0.925 | 0.080 | 11 | 47268596 | missense variant | G/A | snv | 2.2E-04 | 2.6E-04 |
|
0.020 | 1.000 | 2 | 2016 | 2016 | |||||||
|
0.925 | 0.080 | 11 | 47268596 | missense variant | G/A | snv | 2.2E-04 | 2.6E-04 |
|
0.020 | 1.000 | 2 | 2016 | 2016 | |||||||
|
0.716 | 0.360 | 11 | 47264739 | intron variant | T/C | snv | 0.38 |
|
Nervous System Diseases; Mental Disorders | 0.020 | 1.000 | 2 | 2012 | 2013 | |||||||
|
0.827 | 0.280 | 11 | 47255124 | intron variant | A/G | snv | 0.19 |
|
Immune System Diseases; Nervous System Diseases | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||||
|
0.827 | 0.280 | 11 | 47255124 | intron variant | A/G | snv | 0.19 |
|
Nutritional and Metabolic Diseases; Endocrine System Diseases | 0.010 | 1.000 | 1 | 2011 | 2011 | |||||||
|
0.827 | 0.280 | 11 | 47255124 | intron variant | A/G | snv | 0.19 |
|
Digestive System Diseases; Neoplasms; Endocrine System Diseases | 0.010 | 1.000 | 1 | 2011 | 2011 | |||||||
|
0.827 | 0.280 | 11 | 47255124 | intron variant | A/G | snv | 0.19 |
|
Digestive System Diseases; Neoplasms; Endocrine System Diseases | 0.010 | 1.000 | 1 | 2011 | 2011 |